Levosimendan improves renal function in patients with acute decompensated heart failure: Comparison with dobutamine

YILMAZ M. B., Yalta K., Yontar C., Karadas F., Erdem A., TURGUT O. O., ...Daha Fazla

CARDIOVASCULAR DRUGS AND THERAPY, cilt.21, sa.6, ss.431-435, 2007 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 21 Sayı: 6
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1007/s10557-007-6066-7
  • Dergi Adı: CARDIOVASCULAR DRUGS AND THERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.431-435
  • Anahtar Kelimeler: levosimendan, dobutamine, heart failure, renal function, glomerular filtration rate, GLOMERULAR HEMODYNAMICS, CALCIUM SENSITIZER, NITRIC-OXIDE, SEPSIS, RATS
  • Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Background Levosimendan is a relatively new cardiac inotropic agent with calcium sensitizing activity. This study was conducted to investigate the effects of levosimendan (L) and dobutamine (D) on renal function in patients hospitalized with decompensated heart failure (HF).